Ibrahim Halil SAHIN, MD (@ibrahimsahinmd1) 's Twitter Profile
Ibrahim Halil SAHIN, MD

@ibrahimsahinmd1

Medical Oncologist| NCI Colon Task Force|Clinical trialist-Mentor| Research: Precision Medicine-Immunotherapy-Colorectal CA-EOCRC | Patient Advocacy | Musician

ID: 1078819131946876929

calendar_today29-12-2018 01:04:59

2,2K Tweet

3,3K Followers

750 Following

UPMC Heme-Onc Fellowship Program (@upmcheme_onc) 's Twitter Profile Photo

Our hematology-oncology fellows are thrilled to be representing our program at #ASCO25! Excited for all the learning and networking opportunities ahead. The energy is contagious! 🌟 ASCO #Fellowship #MedEd

Our hematology-oncology fellows are thrilled to be representing our program at #ASCO25! Excited for all the learning and networking opportunities ahead. The energy is contagious! 🌟 <a href="/ASCO/">ASCO</a> #Fellowship #MedEd
UPMC Heme-Onc Fellowship Program (@upmcheme_onc) 's Twitter Profile Photo

So proud of our 3rd year fellow, Dr. Singh Meghana Singh, for presenting her Phase II clinical research on the use Zanzalintinib in combination with Durva/Treme for unresectable HCC at #ASCO25 ! 🌟 #Hematology #Oncology #Fellowship

So proud of our 3rd year fellow, Dr. Singh <a href="/MeghanaSinghMD/">Meghana Singh</a>, for presenting her Phase II clinical research on the use Zanzalintinib in combination with Durva/Treme for unresectable HCC at #ASCO25 ! 🌟 #Hematology #Oncology #Fellowship
Smitha Krishnamurthi (@smitha42) 's Twitter Profile Photo

Thank you 🙏🏾 and congratulations 👏🏽Frank Sinicrope, MD and colleagues Alliance for Clinical Trials in Oncology on #ATOMIC! So relieved we are no longer stuck with only chemo for patients with dMMR #ColonCancer in need of adjuvant therapy. Outstanding example of the life-saving research funded by National Cancer Institute !

Pashtoon Kasi MD, MS (@pashtoonkasi) 's Twitter Profile Photo

💡☝🏽Broad panel-based NGS genomic testing🧬for non-metastatic #ColorectalCancer should be in the guidelines: We have ▪️PIK3CA consider testing statement➡️Aspirin💊 Don’t miss your ▪️MSS POL-E patient🟰immunotherapy💉 BRAF, HER2, MSI, & 🔜KRAS for adjuvant➕trials. OncoAlert

💡☝🏽Broad panel-based NGS genomic testing🧬for non-metastatic #ColorectalCancer should be in the guidelines:

We have
▪️PIK3CA consider testing statement➡️Aspirin💊

Don’t miss your
▪️MSS POL-E patient🟰immunotherapy💉 

BRAF, HER2, MSI, &amp; 🔜KRAS for adjuvant➕trials.

<a href="/OncoAlert/">OncoAlert</a>
Colorectal Cancer Alliance (@ccalliance) 's Twitter Profile Photo

"In 2011, at the age of 35, I was diagnosed with Stage IV colon cancer. The cancer had spread to my liver and, eventually, to both of my lungs. For four years, I received chemotherapy systemically through my chest port and injected directly to my liver through my hepatic pump.

"In 2011, at the age of 35, I was diagnosed with Stage IV colon cancer. The cancer had spread to my liver and, eventually, to both of my lungs. For four years, I received chemotherapy systemically through my chest port and injected directly to my liver through my hepatic pump.
UPMC Heme-Onc Fellowship Program (@upmcheme_onc) 's Twitter Profile Photo

Today, we celebrate our Hematology-Oncology Fellowship graduates — physicians whose compassion, brilliance, and resilience have shaped lives and advanced hope. Your dedication is an inspiration. The future of medicine is brighter because of you. 🩸🎓💙 #UPMC #Hematology #Oncology

Today, we celebrate our Hematology-Oncology Fellowship graduates — physicians whose compassion, brilliance, and resilience have shaped lives and advanced hope. Your dedication is an inspiration. The future of medicine is brighter because of you. 🩸🎓💙 #UPMC #Hematology #Oncology
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Early variation in circulating tumor DNA (ctDNA) can predict long-term progression-free and overall survival in patients with dMMR/MSI-H metastatic colorectal cancer treated with immune checkpoint inhibitors. ja.ma/4kLim4U Tougeron David

Early variation in circulating tumor DNA (ctDNA) can predict long-term progression-free and overall survival in patients with dMMR/MSI-H metastatic colorectal cancer treated with immune checkpoint inhibitors. ja.ma/4kLim4U <a href="/david_tougeron/">Tougeron David</a>
UPMC Heme-Onc Fellowship Program (@upmcheme_onc) 's Twitter Profile Photo

We are thrilled to announce Dr. Ben Schluger and Dr. Sarbajeet Nagdas as our new Chief Fellows for this academic year! Your leadership and commitment to Heme-Onc and our program is inspiring. Here's to a bright future ahead! 🎉 #Congrats

We are thrilled to announce Dr. Ben Schluger and Dr. Sarbajeet Nagdas as our new Chief Fellows for this academic year! Your leadership and commitment to Heme-Onc and our program is inspiring. Here's to a bright future ahead! 🎉 #Congrats
Alok Khorana, MD (@aakonc) 's Twitter Profile Photo

Happy 249th Birthday to the country that (among many, many other accomplishments) created the overwhelming majority of all cancer drugs in existence 💪🇺🇸🇺🇸🇺🇸

Sam Garza, MS, MD (@samgarzamd) 's Twitter Profile Photo

It is with heavy hearts that we share the passing of Dr. Samantha Garza. In honor of Sam's life, we invite you to donate in her memory to fund brain tumor research. Thank you to everyone who supported Sam throughout her battle. We love you forever, Sam. gofund.me/94b84c9b